B. Metzler seel. Sohn & Co. AG - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
B. Metzler seel. Sohn & Co. AG ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$572,050
-47.5%
8,185
-46.0%
0.01%
-40.0%
Q2 2023$1,089,398
+148.7%
15,160
+113.5%
0.02%
+114.3%
Q1 2023$437,990
-11.8%
7,101
+10.2%
0.01%
-12.5%
Q4 2022$496,794
+8.0%
6,441
-37.5%
0.01%0.0%
Q3 2022$460,000
+23.0%
10,310
+5.7%
0.01%
+33.3%
Q2 2022$374,000
-7.4%
9,7540.0%0.01%
+20.0%
Q1 2022$404,0009,7540.01%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders